Molecular Imaging of Prostate-Specific Membrane Antigen Using Labeled Technetium-99m BQ0413

NCT06101927 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

10

Enrollment

OTHER

Sponsor class

Conditions

Prostate Cancer

Interventions

DRUG: Whole body study and SPECT with [99mTc]Tc-BQ0413

Sponsor

Tomsk National Research Medical Center of the Russian Academy of Sciences

Collaborators

[object Object]